{"organizations": [], "uuid": "b2ef0eca4d7ff9ee14f1d224016f113b32a6199c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/news/media", "section_title": "Media | Reuters.com", "url": "https://www.reuters.com/article/investment-funds-berkshire/berkshire-buys-teva-bites-more-apple-feels-ibm-blues-idUSL2N1Q420R", "country": "US", "domain_rank": 408, "title": "Berkshire buys Teva, bites more Apple, feels IBM blues", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T05:48:00.000+02:00", "replies_count": 0, "uuid": "b2ef0eca4d7ff9ee14f1d224016f113b32a6199c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/investment-funds-berkshire/berkshire-buys-teva-bites-more-apple-feels-ibm-blues-idUSL2N1Q420R", "ord_in_thread": 0, "title": "Berkshire buys Teva, bites more Apple, feels IBM blues", "locations": [], "entities": {"persons": [{"name": "warren buffett", "sentiment": "negative"}, {"name": "jonathan stempel", "sentiment": "none"}, {"name": "leslie adler", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}], "organizations": [{"name": "berkshire", "sentiment": "negative"}, {"name": "apple", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "ibm", "sentiment": "negative"}, {"name": "berkshire hathaway inc", "sentiment": "negative"}, {"name": "teva", "sentiment": "negative"}, {"name": "apple inc", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}, {"name": "ibm corp", "sentiment": "none"}, {"name": "international business machines corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Warren Buffett’s Berkshire Hathaway Inc on Wednesday said it has taken a new stake in Teva Pharmaceutical Industries Ltd, significantly boosted its holdings of Apple Inc and has nearly shed a less successful investment in IBM Corp.\nIn a regulatory filing detailing its U.S.-listed stock holdings as of Dec. 31, Berkshire reported owning about 18.9 million of the American depositary receipts in Teva, one of the world’s largest generic drug makers, worth about $358 million.\nTeva’s share price rose more than 10 percent after Berkshire reported its ownership stake.\nBerkshire also reported a 23 percent increase since the end of September in its Apple stake, to about 165.3 million shares, and a 94.5 percent decline in its stake in International Business Machines Corp, to 2.05 million shares. (Reporting by Jonathan Stempel in New York; Editing by Leslie Adler)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-15T05:48:00.000+02:00", "crawled": "2018-02-15T10:36:15.003+02:00", "highlightTitle": ""}